Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting

J Am Acad Dermatol. 2020 May;82(5):1247-1249. doi: 10.1016/j.jaad.2019.12.039. Epub 2019 Dec 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Chemokine CCL17 / blood*
  • Conjunctivitis / chemically induced
  • Conjunctivitis / epidemiology*
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Humans
  • Immunoglobulin E / blood*
  • Middle Aged
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Humanized
  • CCL17 protein, human
  • Chemokine CCL17
  • Immunoglobulin E
  • dupilumab